Potential of creatine or phosphocreatine supplementation in cerebrovascular disease and in ischemic heart disease
The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Creatine is of paramount importance for maintaining and managing cellular ATP stores in both physiological and pathological states. Besides these "ergogenic" actions, it has a number of additional "pleiotropic" effects, e.g., antioxidant activity, neurotransmitter-like behavior, prevention of opening of mitochondrial permeability pore and others. Creatine supplementation has been proposed for a number of conditions, including neurodegenerative diseases. However, it is likely that creatine's largest therapeutic potential is in those diseases caused by energy shortage or by increased energy demand; for example, ischemic stroke and other cerebrovascular diseases. Surprisingly, despite a large preclinical body of evidence, little or no clinical research has been carried out in these fields. However, recent work showed that high-dose creatine supplementation causes an 8-9 % increase in cerebral creatine content, and that this is capable of improving, in humans, neuropsychological performances that are hampered by hypoxia. In addition, animal work suggests that creatine supplementation may be protective in stroke by increasing not only the neuronal but also the endothelial creatine content. Creatine should be administered before brain ischemia occurs, and thus should be given for prevention purposes to patients at high risk of stroke. In myocardial ischemia, phosphocreatine has been used clinically with positive results, e.g., showing prevention of arrhythmia and improvement in car…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the CK/PCr system thereby serves as an important regulator of metabolism which may help explain the ergogenic and potential therapeutic health benefits of creatine supplementation”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [33]
In the citing paper
“This coupling also reduces the formation of reactive oxygen species (ROS) and can therefore act as a direct and/or indirect antioxidant”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [33]
In the citing paper
“These findings provide strong evidence that creatine supplementation may limit damage from concussions, TBI, and/or SCI”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [33]
In the citing paper
“In a recent review, Balestrino and colleagues [33] concluded that phosphocreatine administration, primarily as an addition to cardioplegic solutions, has been used to treat myocardial ischemia and prevent ischemia-induced arrhythmia and improve cardiac function with some success.”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [33]
In the citing paper
“Creatine and phosphocreatine play an important role in maintaining myocardial bioenergetics during ischemic events [33].”
From International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine (2017) · cites this paper as [33]
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417
Recommendations for Standards Regarding Preclinical Neuroprotective and Restorative Drug Development
(1999) · Stroke · doi:10.1161/01.str.30.12.2752 · Cited by 1,251
The creatine kinase system and pleiotropic effects of creatine
Wallimann, T., Tokarska-Schlattner, M., & Schlattner, U. (2011) · Amino Acids · doi:10.1007/s00726-011-0877-3 · Cited by 797
Lauritzen, M., Dreier, J. P., Fabricius, M., Hartings, J. A., Graf, R., & Strong, A. J. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.191 · Cited by 782
Neubauer, S., Horn, M., Cramer, M., Harre, K., Newell, J. B., Peters, W., Pabst, T., Ertl, G., Hahn, D., Ingwall, J. S., et al. (1997) · Circulation · doi:10.1161/01.cir.96.7.2190 · Cited by 745
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
Klivenyi, P., Ferrante, R. J., Matthews, R. T., Bogdanov, M. B., Klein, A. M., Andreassen, O. A., Mueller, G., Wermer, M., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Nature Medicine · doi:10.1038/6568 · Cited by 682
Neuroprotective Effects of Creatine in a Transgenic Mouse Model of Huntington's Disease
Ferrante, R. J., Andreassen, O. A., Jenkins, B. G., Dedeoglu, A., Kuemmerle, S., Kubilus, J. K., Kaddurah-Daouk, R., Hersch, S. M., & Beal, M. F. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04389.2000 · Cited by 522
Creatine and Cyclocreatine Attenuate MPTP Neurotoxicity
Matthews, R. T., Ferrante, R. J., Klivenyi, P., Yang, L., Klein, A. M., Mueller, G., Kaddurah-Daouk, R., & Beal, M. F. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7049 · Cited by 373
Functions and effects of creatine in the central nervous system
Andres, R. H., Ducray, A. D., Schlattner, U., Wallimann, T., & Widmer, H. R. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.02.035 · Cited by 368
Increase of total creatine in human brain after oral supplementation of creatine-monohydrate
Dechent, P., Pouwels, P. J. W., Wilken, B., Hanefeld, F., & Frahm, J. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.277.3.r698 · Cited by 221
The role of creatine kinase in inhibition of mitochondrial permeability transition
(1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01045-4 · Cited by 210
Lipton, P., & Whittingham, T. S. (1982) · The Journal of Physiology · doi:10.1113/jphysiol.1982.sp014135 · Cited by 210
Kieburtz, K., Tilley, B. C., Elm, J. J., Babcock, D., Hauser, R., Ross, G. W., Augustine, A. H., Augustine, E. U., Aminoff, M. J., Bodis-Wollner, I. G., et al. (2015) · JAMA · doi:10.1001/jama.2015.120 · Cited by 207
Sestili, P., Martinelli, C., Colombo, E., Barbieri, E., Potenza, L., Sartini, S., & Fimognari, C. (2011) · Amino Acids · doi:10.1007/s00726-011-0875-5 · Cited by 200
Ohtsuki, S., Tachikawa, M., Takanaga, H., Shimizu, H., Watanabe, M., Hosoya, K.-I., & Terasaki, T. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200211000-00006 · Cited by 196
Inhibition of the Mitochondrial Permeability Transition by Creatine Kinase Substrates
Dolder, M., Walzel, B., Speer, O., Schlattner, U., & Wallimann, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208705200 · Cited by 194
Kübler, W., & Katz, A. M. (1977) · The American Journal of Cardiology · doi:10.1016/0002-9149(77)90174-6 · Cited by 192
Neuroprotective effects of creatine
Beal, M. F. (2011) · Amino Acids · doi:10.1007/s00726-011-0851-0 · Cited by 188
Extracellular creatine regulates creatine transport in rat and human muscle cells.
Loike, J. D., Zalutsky, D. L., Kaback, E., Miranda, A. F., & Silverstein, S. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.3.807 · Cited by 170
McMorris, T., Harris, R. C., Swain, J., Corbett, J., Collard, K., Dyson, R. J., Dye, L., Hodgson, C., & Draper, N. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0269-z · Cited by 168
Scientific basis and practical aspects of creatine supplementation for athletes
Volek, J. S., & Rawson, E. S. (2004) · Nutrition · doi:10.1016/j.nut.2004.04.014 · Cited by 159
Turner, C. E., Byblow, W. D., & Gant, N. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3113-14.2015 · Cited by 157
Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases
Chaturvedi, R. K., & Beal, M. F. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.11.011 · Cited by 143
Neubauer, S., Remkes, H., Spindler, M., Horn, M., Wiesmann, F., Prestle, J., Walzel, B., Ertl, G., Hasenfuss, G., & Wallimann, T. (1999) · Circulation · doi:10.1161/01.cir.100.18.1847 · Cited by 140
Lyoo, I. K., Kong, S. W., Sung, S. M., Hirashima, F., Parow, A., Hennen, J., Cohen, B. M., & Renshaw, P. F. (2003) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(03)00046-5 · Cited by 140
Exocytotic release of creatine in rat brain
Almeida, L. S., Salomons, G. S., Hogenboom, F., Jakobs, C., & Schoffelmeer, A. N. M. (2006) · Synapse · doi:10.1002/syn.20280 · Cited by 139
Prophylactic Creatine Administration Mediates Neuroprotection in Cerebral Ischemia in Mice
Zhu, S., Li, M., Figueroa, B. E., Liu, A., Stavrovskaya, I. G., Pasinelli, P., Beal, M. F., Brown, R. H., Kristal, B. S., Ferrante, R. J., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1278-04.2004 · Cited by 138
Improved Reperfusion and Neuroprotection by Creatine in a Mouse Model of Stroke
Prass, K., Royl, G., Lindauer, U., Freyer, D., Megow, D., Dirnagl, U., Stöckler-Ipsiroglu, G., Wallimann, T., & Priller, J. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600351 · Cited by 128
Trends in the Molecular Pathogenesis and Clinical Therapeutics of Common Neurodegenerative Disorders
Choonara, Y. E., Pillay, V., Du Toit, L. C., Modi, G., Naidoo, D., Ndesendo, V. M. K., & Sibambo, S. R. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10062510 · Cited by 123
ten Hove, M., Lygate, C. A., Fischer, A., Schneider, J. E., Sang, A. E., Hulbert, K., Sebag‐Montefiore, L., Watkins, H. C., Clarke, K., Isbrandt, D., et al. (2005) · Circulation · doi:10.1161/01.cir.0000165147.99592.01 · Cited by 121
Deldicque, L., Theisen, D., Bertrand, L., Hespel, P., Hue, L., & Francaux, M. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00162.2007 · Cited by 117
Creatine supplementation, sleep deprivation, cortisol, melatonin and behavior
McMorris, T., Harris, R. C., Howard, A. N., Langridge, G., Hall, B., Corbett, J., Dicks, M., & Hodgson, C. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.08.024 · Cited by 115
Hall, M., & Trojian, T. H. (2013) · Current Sports Medicine Reports · doi:10.1249/jsr.0b013e31829cdff2 · Cited by 112
Balestrino, M., & Somjen, G. G. (1986) · Brain Research · doi:10.1016/0006-8993(86)91067-x · Cited by 110
Self-citationCreatine monohydrate in ALS: Effects on strength, fatigue, respiratory status and ALSFRS
Rosenfeld, J., King, R. M., Jackson, C. E., Bedlack, R. S., Barohn, R. J., Dick, A., Phillips, L. H., Chapin, J., Gelinas, D. F., & Lou, J.-S. (2008) · Amyotrophic Lateral Sclerosis · doi:10.1080/17482960802028890 · Cited by 107
Pathophysiology of anoxic depolarization: new findings and a working hypothesis
Balestrino, M. (1995) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(94)00199-q · Cited by 106
Self-citationMitochondria and ALS: Implications from novel genes and pathways
Cozzolino, M., Ferri, A., Valle, C., & Carrì, M. T. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.06.001 · Cited by 104
Lygate, C. A., Aksentijevic, D., Dawson, D., ten Hove, M., Phillips, D., de Bono, J. P., Medway, D. J., Sebag-Montefiore, L., Hunyor, I., Channon, K. M., et al. (2013) · Circulation Research · doi:10.1161/circresaha.112.300725 · Cited by 104
Cerebral Synaptic Transmission During Anoxia Is Protected by Creatine
Whittingham, T. S., & Lipton, P. (1981) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1981.tb06337.x · Cited by 99
Cyclocreatine treatment improves cognition in mice with creatine transporter deficiency
Kurosawa, Y., DeGrauw, T. J., Lindquist, D. M., Blanco, V. M., Pyne-Geithman, G. J., Daikoku, T., Chambers, J. B., Benoit, S. C., & Clark, J. F. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59373 · Cited by 98
PRECREST: A phase II prevention and biomarker trial of creatine in at-risk Huntington disease
Rosas, H. D., Doros, G., Gevorkian, S., Malarick, K., Reuter, M., Coutu, J.-P., Triggs, T. D., Wilkens, P. J., Matson, W., Salat, D. H., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000187 · Cited by 98
Adcock, K. H., Nedelcu, J., Loenneker, T., Martin, E., Wallimann, T., & Wagner, B. P. (2002) · Developmental Neuroscience · doi:10.1159/000069043 · Cited by 97
Balestrino, M., Rebaudo, R., & Gianluigi, L. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01131-7 · Cited by 91
Self-citationLygate, C. A., Bohl, S., ten Hove, M., Faller, K. M. E., Ostrowski, P. J., Zervou, S., Medway, D. J., Aksentijevic, D., Sebag-Montefiore, L., Wallis, J., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs272 · Cited by 88
Creatine phosphate: An additive myocardial protective and antiarrhythmic agent in cardioplegia
Robinson, L. A., Braimbridge, M. V., Hearse, D. J., & Jones, R. H. (1984) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)37413-6 · Cited by 86
Carter, A. J., Müller, R. E., Pschorn, U., & Stransky, W. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64062691.x · Cited by 83
Tokarska-Schlattner, M., Epand, R. F., Meiler, F., Zandomeneghi, G., Neumann, D., Widmer, H. R., Meier, B. H., Epand, R. M., Saks, V., Wallimann, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043178 · Cited by 81
Kinetics of creatine in blood and brain after intraperitoneal injection in the rat
Perasso, L., Cupello, A., Lunardi, G. L., Principato, M. C., Gandolfo, C., & Balestrino, M. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02547-2 · Cited by 76
Self-citationDickinson, H., Ellery, S., Ireland, Z., LaRosa, D., Snow, R., & Walker, D. W. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-150 · Cited by 74
Protection of ischemic myocardium by exogenous phosphocreatine
Sharov, V. G., Saks, V. A., Kupriyanov, V. V., Lakomkin, V. L., Kapelko, V. I., Steinschneider, A. Y., & Javadov, S. A. (1987) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)36191-4 · Cited by 73
Effects of creatine supplementation on homocysteine levels and lipid peroxidation in rats
Deminice, R., Portari, G. V., Vannucchi, H., & Jordao, A. A. (2008) · British Journal of Nutrition · doi:10.1017/s0007114508162985 · Cited by 71
Creatine Protects the Central Respiratory Network of Mammals under Anoxic Conditions
Wilken, B., Ramirez, J., Probst, I., Richter, D. W., & Hanefeld, F. A. (1998) · Pediatric Research · doi:10.1203/00006450-199801000-00002 · Cited by 70
Creatine Phosphate: Pharmacological and Clinical Perspectives
Strumia, E., Pelliccia, F., & D’Ambrosio, G. (2012) · Advances in Therapy · doi:10.1007/s12325-011-0091-4 · Cited by 68
Neuroprotection Does Not Work!
Röther, J. (2008) · Stroke · doi:10.1161/strokeaha.107.494799 · Cited by 67
Lensman, M. V., Korzhevsky, D. E., Mourovets, V. O., Kostkin, V. B., Izvarina, N. L., Perasso, L., Gandolfo, C., Otellin, V. A., Polenov, S. A., & Balestrino, M. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.103 · Cited by 65
Self-citationThe effect of graded hypoxia on the hippocampal slice: an in vitro model of the ischemic penumbra.
Schiff, S. J., & Somjen, G. G. (1987) · Stroke · doi:10.1161/01.str.18.1.30 · Cited by 63
Andres, R. H., Ducray, A. D., Huber, A. W., Pérez‐Bouza, A., Krebs, S. H., Schlattner, U., Seiler, R. W., Wallimann, T., & Widmer, H. R. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03337.x · Cited by 58
Horn, M., Remkes, H., Strömer, H., Dienesch, C., & Neubauer, S. (2001) · Circulation · doi:10.1161/hc3901.095933 · Cited by 56
Lunardi, G. L., Parodi, A., Perasso, L., Pohvozcheva, A. V., Scarrone, S., Adriano, E., Florio, T., Gandolfo, C., Cupello, A., Burov, S. V., et al. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.058 · Cited by 53
Self-citationHorn, M., Frantz, S., Remkes, H., Laser, A., Urban, B., Mettenleiter, A., Schnackerz, K. D., & Neubauer, S. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1997.0590 · Cited by 53
Anoxic depolarization determines ischemic brain injury
Kaminogo, M., Suyama, K., Ichikura, A., Onizuka, M., & Shibata, S. (1998) · Neurological Research · doi:10.1080/01616412.1998.11740529 · Cited by 52
Creatine Protects against Excitoxicity in an In Vitro Model of Neurodegeneration
Genius, J., Geiger, J., Bender, A., Möller, H.-J., Klopstock, T., & Rujescu, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030554 · Cited by 51
Creatine Phosphate Suppresses Ventricular Arrhythmias Resulting from Coronary Artery Ligation
Fagbemi, O., Kane, K. A., & Parratt, J. R. (1982) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-198201000-00009 · Cited by 46
Ruda, M. Y., Samarenko, M. B., Afonskaya, N. I., & Saks, V. A. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90611-4 · Cited by 46
Parratt, J. R., & Marshall, R. (1974) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1974.tb09308.x · Cited by 45
Protection of isolated rat heart from oxidative stress by exogenous creatine phosphate
Zucchi, R. (1989) · Journal of Molecular and Cellular Cardiology · doi:10.1016/0022-2828(89)91494-6 · Cited by 43
Therapeutic use of creatine in brain or heart ischemia: Available data and future perspectives
Perasso, L., Spallarossa, P., Gandolfo, C., Ruggeri, P., & Balestrino, M. (2013) · Medicinal Research Reviews · doi:10.1002/med.20255 · Cited by 43
Self-citationWoznicki, D. T., & Walker, J. B. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb09966.x · Cited by 42
Osbakken, M., Ito, K., Zhang, D., Ponomarenko, I., Ivanics, T., Jahngen, E. G. E., & Cohn, M. (1992) · Cardiology · doi:10.1159/000175002 · Cited by 40
Basketball Injuries: Caring for a Basketball Team
Trojian, T. H., Cracco, A., Hall, M., Mascaro, M., Aerni, G., & Ragle, R. (2013) · Current Sports Medicine Reports · doi:10.1097/01.csmr.0000434055.36042.cd · Cited by 39
Branovets, J., Sepp, M., Kotlyarova, S., Jepihhina, N., Sokolova, N., Aksentijević, D., Lygate, C. A., Neubauer, S., Vendelin, M., & Birkedal, R. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00919.2012 · Cited by 36
Marshall, R., & Parratt, J. R. (1974) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00499438 · Cited by 32
In vivo neuroprotection by a creatine-derived compound: Phosphocreatine–Mg-complex acetate
Perasso, L., Adriano, E., Ruggeri, P., Burov, S. V., Gandolfo, C., & Balestrino, M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.06.009 · Cited by 31
Self-citationDucray, A. D., Schläppi, J., Qualls, R., Andres, R. H., Seiler, R. W., Schlattner, U., Wallimann, T., & Widmer, H. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21337 · Cited by 31
Allah Yar, R., Akbar, A., & Iqbal, F. (2015) · Brain Research · doi:10.1016/j.brainres.2014.11.017 · Cited by 30
Protective Effects of Some Creatine Derivatives in Brain Tissue Anoxia
Perasso, L., Lunardi, G. L., Risso, F., Pohvozcheva, A. V., Leko, M. V., Gandolfo, C., Florio, T., Cupello, A., Burov, S. V., & Balestrino, M. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9492-9 · Cited by 29
Self-citationCreatine and creatine analogues in hypertension and cardiovascular disease
Horjus, D. L., Oudman, I., van Montfrans, G. A., & Brewster, L. M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005184.pub2 · Cited by 28
Yoneda, K., & Okada, Y. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90187-5 · Cited by 27
Sestili, P., Barbieri, E., & Stocchi, V. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666150722102342 · Cited by 26
St. Thomas' Hospital cardioplegia: Enhanced protection with exogenous creatine phosphate
Chambers, D. J., Haire, K., Morley, N., Fairbanks, L., Strumia, E., Young, C. P., & Venn, G. E. (1996) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00819-5 · Cited by 25
Allen, P. J., DeBold, J. F., Rios, M., & Kanarek, R. B. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.12.014 · Cited by 25
Diffusion-weighted single-shot line scan imaging of the human brain
Finsterbusch, J., & Frahm, J. (1999) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(199910)42:4<803::aid-mrm24>3.0.co;2-f · Cited by 25
Brain water diffusion in normal and creatine-supplemented rats during transient global ischemia
Wick, M., Fujimori, H., Michaelis, T., & Frahm, J. (1999) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(199910)42:4<798::aid-mrm23>3.0.co;2-o · Cited by 25
Woo, Y.-P. J., Grand, T. J., Zentko, S. E., Cohen, J. E., Hsu, V. M., Atluri, P., Berry, M. F., Taylor, M. D., Moise, M. A., Fisher, O., et al. (2005) · PubMed · Cited by 24
Adriano, E., Garbati, P., Damonte, G., Salis, A., Armirotti, A., & Balestrino, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.09.018 · Cited by 23
Self-citationFeeding a creatine analogue delays ATP depletion and onset of rigor in ischemic heart
Roberts, J., & Walker, J. B. (1982) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1982.243.6.h911 · Cited by 23
Neubauer, S., Hu, K., Horn, M., Remkes, H., Hoffmann, K. D., Schmidt, C., Schmidt, T. J., Schnackerz, K. D., & Ertl, G. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1016 · Cited by 22
High-Energy Phosphate Metabolism in Normal, Hypertrophied and Failing Human Myocardium
Neubauer, S. (1999) · Heart Failure Reviews · doi:10.1023/a:1009866108384 · Cited by 21
Creatine phosphate and protection against reperfusion-induced arrhythmias in the rat heart
Hearse, D. J., Tanaka, K., Crome, R., & MANNING, A. S. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90511-x · Cited by 21
Uptake of creatine phosphate into heart mitochondria: a leak in the creatine shuttle
Soboll, S., Conrad, A., Eistert, A., Herick, K., & Krämer, R. (1997) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(97)00004-2 · Cited by 20
Yoneda, K., Arakawa, T., Asaoka, Y., Fukuoka, Y., KINUGASA, K., Takimoto, K., & Okada, Y. (1983) · Experimental Neurology · doi:10.1016/0014-4886(83)90256-x · Cited by 19
Pastoris, O., Dossena, M., Vercesi, L., Bruseghini, M., Pagnin, A., & Ceriana, P. (1991) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1016/1053-0770(91)90122-a · Cited by 17
[Molecular and cellular aspects of the cardioprotective mechanism of phosphocreatine].
Saks, V. A., Dzhaliashvili, I. V., Konorev, E. A., & Strumia, E. (1992) · PubMed · Cited by 17
Chen, G., Guo, J.-H., Xuan, H., Jinyi, W., Lü, R., & Liu, Z. (2012) · Coronary Artery Disease · doi:10.1097/mca.0b013e32835aab95 · Cited by 15
Savitz, S. I., & Fisher, M. (2007) · Current Drug Targets · doi:10.2174/138945007781077382 · Cited by 15
A Prophylactic Role for Creatine in Hypoxia?
Engl, E., & Garvert, M. M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1195-15.2015 · Cited by 14
Electrophysiology and biochemical analysis of cyclocreatine uptake and effect in hippocampal slices
Enrico, A., Garbati, P., Perasso, L., Parodi, A., Gianluigi, L., Gandolfo, C., & Balestrino, M. (2013) · Journal of Integrative Neuroscience · doi:10.1142/s0219635213500155 · Cited by 13
Self-citationWebster, I., Toit, E. F. D., Huisamen, B., & Lochner, A. (2012) · Acta Physiologica · doi:10.1111/j.1748-1716.2012.02463.x · Cited by 11
The Neuroprotective Effect of Creatine in Rats with Cerebral Ischemia
Otellin, V. A., Korzhevsky, D. E., Kostkin, V. B., Balestrino, M., Lensman, M. V., & Polenov, S. A. (2003) · Doklady Biological Sciences · doi:10.1023/a:1024432911738 · Cited by 10
Self-citationEvidence for a Relation between Creatine Phosphate Level and Polarity of the Cerebral Cortex
Krivanek, J., Bureš, J., & Burešová, O. (1958) · Nature · doi:10.1038/1821799a0 · Cited by 8
Myocardial protection during ischemia by prior feeding with the creatine analog: Cyclocreatine
Jacobstein, M. D., Gerken, T. A., Bhat, A. M., & Carlier, P. G. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90081-8 · Cited by 8
Structural organization of astrocytes in the rat hippocampus in the post-ischemic period
Korzhevsky, D. E., Otellin, V. A., Grigor’ev, I. P., Kostkin, V. B., Polenov, S. A., Ленцман, М. В., & Balestrino, M. (2005) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-005-0038-9 · Cited by 7
Self-citationПанченко, Е. П., Борисович, Д. А., Рогоза, А. Н., Владимирович, С. Е., Агеева, Н. В., Маркова, Л. И., Владимировна, Т. Е., Vv, A., IuA, K., & Saks, V. A. (1994) · PubMed · Cited by 7
Artru, A. A., & Michenfelder, J. D. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb11517.x · Cited by 6
Iqbal, S., Nazir, N., Gillani, Q., Akbar, A., & Iqbal, F. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/286075 · Cited by 6
Neubauer, S., Horn, M., & Schnackerz, K. D. (1998) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/bf02660931 · Cited by 4
[Possible mechanism of the protective effect of phosphocreatine on the ischemic myocardium].
Preobrazhenskiĭ, A. N., Dzhavadov, S. A., & Saks, V. A. (1986) · PubMed · Cited by 3
Nv, K., Веселкина, О. С., Kolpakova, M. E., Sg, C., Korzhevsky, D. E., As, D., Ms, P., Av, P., & Vlasov, T. D. (2012) · PubMed · Cited by 1
Research works printed but not linked: 6
- Coraggio F, Spina M, Scarpato P (1987) Analysis of creatine phosphate on the evolution of ischemic lesion in acute myocardial infarction. Farmaci Terapia 4:91–93
- Ingwall JS (1993) Is cardiac failure a consequence of decreased energy reserve? Circulation 87:58–62
- Iosseliani DG, Koledinsky AG, Kuchkina NV (2004) Does intracoronary injection of phosphocreatine prevent myocardial reperfusion injury following angioplasty of infarct-related artery in acute-stage of myocardial infarction? J Intervent Cardiol 6:10–14
- Iosseliani DG, Koledinsky AG, Kuchkina NV (2006) The possibility to limit reperfusion injury of cardiomyocytes using intracoronary cytoprotectors during endovascular reperfusion of the infarct-related artery. J Intervent Cardiol 11:10–16
- Raisaro A, Bargiggia CS, Bertucci C (1989) Clinical evaluation of phosphocreatine effect during acute myocardial infarction: A multicenter study: 139147. Proceedings of the International Meeting “Cardioprotection with phosphocreatine in cardiology and cardiac surgery” IRCCS, Policlinico S. Matteo, Università degli studi, Pavia
- Skřivánek O, Kalvach Pavel, Benetin Ján, Brzák M, Kukumberg I, Strnad P, Strnadová V, Traubner Pavol, Turčány P, Vávra P (1995) Waberžinek, Gerhard. Kreatinfosfát v léčbě akutních ischemických iktů. Prakticky Lekar 75:7–8
Cited by
Kreider, R. B., Kalman, D. S., Antonio, J., Ziegenfuss, T. N., Wildman, R., Collins, R., Candow, D. G., Kleiner, S. M., Almada, A. L., & Lopez, H. L. (2017) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-017-0173-z · Cited by 1,057
“In a recent review, Balestrino and colleagues [33] concluded that phosphocrea-”
BackgroundWu, G. (2020) · Amino Acids · doi:10.1007/s00726-020-02823-6 · Cited by 475
Antonio, J., Candow, D. G., Forbes, S. C., Gualano, B., Jagim, A. R., Kreider, R. B., Rawson, E. S., Smith-Ryan, A. E., VanDusseldorp, T. A., Willoughby, D. S., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-021-00412-w · Cited by 345
“Finally, there is evidence from animal models that creatine supplementation is neuroprotective [147–149] and can reduce the severity of spinal cord injury [150, 151], cerebral ischemia [152–155], and concussion/traumatic brain injury [2, 7, 12, 22, 32, 33, 156].”
BackgroundCreatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
“Creatine supplementation has been reported to increase brain PCr content by 5–15% and thereby enhance brain bioenergetics [21,53,69,131,171].”
BackgroundInfluentialBalestrino, M., & Adriano, E. (2019) · Medicinal Research Reviews · doi:10.1002/med.21590 · Cited by 90
“This auspice originates from the strong rationale for its effectiveness and from the impressive amount of preclinical data showing the effectiveness of creatine pretreatment in reducing ischemic damage.(16,17) Importantly, clinical experience in the past couple of decades has largely reassured on the safety of creatine”
BackgroundSelf-citation
Metadata
- Authors
- Balestrino, M., Sarocchi, M., Adriano, E., & Spallarossa, P.
- Affiliations
- University of Genoa (IT)
- Corresponding author
- Balestrino, Maurizio
- Venue
- Amino Acids
- Published
- 2016-01-21
- Volume
- 48
- Issue
- 8
- Pages
- 1955-1967
- ISSN
- 0939-4451 (ISSN-L)
- 1438-2199
- OpenAlex
- W2275117202
- Cited by
- 60
- References
- 108
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 4 · 2023: 7 · 2022: 7 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 2 · 2016: 4
- FWCI
- 0.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Amino Acids (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Funders
- Telethon Italy (GEP 13019)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Health Sciences › Medicine › Physiology (medical) › Biochemical effects in animals
- Keywords
- creatine supplementation, phosphocreatine, cerebrovascular disease, ischemic stroke, ischemic heart disease, myocardial ischemia, hypoxia, antioxidant activity, cardioplegic solution, arrhythmia prevention, reperfusion
- MeSH terms
- Animals, Hypoxia, Brain, Humans, Phosphocreatine, Myocardial Ischemia, Dietary Supplements, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.